CUSIP: 71426V108
Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,250,371
-
Share change
-
+3,171,339
-
Total reported value
-
$186,234,467
-
Put/Call ratio
-
202%
-
Price per share
-
$7.68
-
Number of holders
-
76
-
Value change
-
+$23,234,390
-
Number of buys
-
39
-
Number of sells
-
44
Quarterly Holders Quick Answers
What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2014
-
Previous quarter:
Q2 2014
Recent filing periods for CUSIP 71426V108:
Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q3 2014
As of 30 Sep 2014,
PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,250,371 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, Broadfin Capital, LLC, Consonance Capital Management LP, BANK OF MONTREAL /CAN/, WALL STREET ASSOCIATES, ORBIMED ADVISORS LLC, BlackRock Institutional Trust Company, N.A., KOPP INVESTMENT ADVISORS LLC, BlackRock Fund Advisors, and KENNEDY CAPITAL MANAGEMENT, INC..
This page lists
76
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.